quadraScope Ventures
Boston, MA, United States
Overview
quadraScope is an investment management company that invests in early-stage healthcare companies.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Finance
- Financial Services
- Venture Capital
Investment portfolio
- Matter Bio
Participated · Seed · May 2024
Matter Bio develops multi-pronged biotechnologies to preserve genome integrity and address aging-related decline. The company’s platform centers on reading mutations, reversing integrated mutations by reintroducing original genetic information, and removing irreparably damaged cells such as cancerous, clonal, and senescent cells. It applies these approaches to study the information theory of aging at a genomic level and to therapeutic development. Matter Bio plans to use recent funding to file an IND and initiate a Phase 1/2a clinical trial in solid cancer. The team includes co-founders George Church, Jan Vijg, and Claudia Gravekamp. Financially, the company closed a $7M Seed round and has grant support from NIH, NCI, and NIEHS.
Team
No current team members are available.